2m 2m 2m 2m 2m 2m 2m
NRC Health (NRC)
NASDAQ
$19.04-$0.55 (-2.83%)
Price as of Jun 03, 2026 4:10 PM EDT- $443.1MMarket Cap
- 43.52%1-Year Change
- Health Information ServicesIndustry
NRC Health (NRC)
$19.04-$0.55 (-2.83%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 137.4M -3.96% | 143.1M -3.72% | 148.6M -1.97% | 151.6M +2.44% | |
Cost of Revenue | 52.4M -8.01% | 56.9M +1.64% | 56.0M -1.81% | 57.0M +8.98% | |
Gross Profit | 85.0M -1.29% | 86.1M -6.96% | 92.6M -2.07% | 94.5M -1.13% | |
Sales and Marketing Expense | 54.8M +22.03% | 44.9M -3.67% | 46.6M +9.19% | 42.7M +9.60% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 7.6M +31.45% | 5.8M 0.00% | 5.8M +13.73% | 5.1M -10.53% | |
Total Operating Expenses | 114.8M +6.43% | 107.9M -0.62% | 108.5M +3.34% | 105.0M +7.52% | |
Operating Profit | 22.6M -35.81% | 35.2M -12.11% | 40.0M -13.96% | 46.5M -7.41% | |
Interest Income | 111,000 -11.20% | 125,000 -84.76% | 820,000 +388.10% | 168,000 +1,100.00% | |
Interest Expense | N/A N/A | -2.6M +201.04% | -862,000 -28.70% | -1.2M -27.47% | |
Interest Income and Expense and Net | 111,000 +104.49% | -2.5M +5,780.95% | -42,000 -95.97% | -1.0M -37.02% | |
Total Nonoperating Income and Expense | -4.7M +89.50% | -2.5M +2,916.87% | -83,000 -97.77% | -3.7M +126.08% | |
Income before Taxes | 17.8M -45.41% | 32.7M -18.20% | 40.0M -6.66% | 42.8M -11.94% | |
Income Taxes | 6.2M -21.02% | 7.9M -12.06% | 9.0M -18.37% | 11.0M -1.26% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | 11.6M -53.19% | 24.8M -19.98% | 31.0M -2.61% | 31.8M -15.12% | |
Net Income from Continuing Operations Applicable to Common | 17.8M -45.41% | 32.7M -18.20% | 40.0M -6.66% | 42.8M -11.94% | |
Basic EPS and Net Income | 50.00 +4,661.90% | 1.05 -16.67% | 1.26 -1.56% | 1.28 -12.93% | |
Diluted EPS and Net Income | 50.00 +4,707.69% | 1.04 -16.80% | 1.25 -1.57% | 1.27 -13.01% | |
Basic Weighted Average Shares | 22.4M -5.57% | 23.7M -3.41% | 24.5M -1.53% | 24.9M -1.97% | |
Diluted Weighted Average Shares | 22.4M -5.67% | 23.7M -3.77% | 24.7M -1.51% | 25.1M -2.29% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.1M -2.22% | 4.2M -36.37% | 6.7M -73.42% | 25.0M -53.96% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.1M -2.22% | 4.2M -36.37% | 6.7M -73.42% | 25.0M -53.96% | |
Total Current Assets | 20.2M +3.11% | 19.6M -19.54% | 24.4M -44.28% | 43.7M -40.69% | |
Accumulated Depreciation | 40.7M +15.11% | 35.4M -0.80% | 35.7M +6.45% | 33.5M +0.90% | |
Property and Plant and Equipment and Net | 40.5M +5.76% | 38.3M +35.68% | 28.2M +63.53% | 17.2M +39.20% | |
Total Long-Term Assets | 3.3M +22.30% | 2.7M -17.14% | 3.3M +0.40% | 3.3M -0.49% | |
Total Assets | 134.9M +1.76% | 132.5M +8.25% | 122.4M -6.15% | 130.5M -17.19% | |
Income Taxes Payable | 6.5M +68.23% | 3.9M -10.94% | 4.4M -17.31% | 5.3M -24.68% | |
Total Short-Term Debt | 4.0M -16.18% | 4.8M -33.62% | 7.2M +60.63% | 4.5M +4.98% | |
Total Current Liabilities | 36.6M +2.13% | 35.9M -0.95% | 36.2M +8.34% | 33.4M -17.26% | |
Total Long-Term Debt | 75.0M +29.58% | 57.9M +96.45% | 29.5M +66.59% | 17.7M -20.56% | |
Total Long-Term Liabilities | 3.3M -10.65% | 3.7M -0.49% | 3.7M +79.29% | 2.0M -19.54% | |
Total Liabilities | 120.9M +19.39% | 101.3M +37.80% | 73.5M +25.77% | 58.4M -19.08% | |
Retained Earnings | -17.3M +1.37% | -17.1M -44.11% | -30.5M +21.23% | -25.2M -30.26% | |
Total Stockholders Equity | 14.0M -55.28% | 31.3M -36.10% | 49.0M -32.04% | 72.0M -15.59% | |
Total Shares Outstanding | 22.6M -1.93% | 23.1M -4.69% | 24.2M -1.66% | 24.6M -2.89% | |
Cash Flow | |||||
Cash from Operating Activities | 26.4M -23.61% | 34.6M -9.15% | 38.1M +5.10% | 36.3M -21.75% | |
Capital Expenditures | 10.7M -30.70% | 15.4M -2.10% | 15.8M +60.44% | 9.8M +78.36% | |
Cash from Investing Activities | -10.7M -47.21% | -20.3M +28.54% | -15.8M +60.43% | -9.8M +15.52% | |
Dividends Paid | 11.0M -4.15% | 11.5M -68.51% | 36.4M +73.49% | 21.0M +128.86% | |
Cash from Financing Activities | -15.8M -5.52% | -16.8M -58.82% | -40.7M -26.76% | -55.6M +206.04% | |
Financials Ratio | |||||
Gross Margin | 61.88% +2.79% | 60.20% -3.37% | 62.30% -0.10% | 62.36% -3.49% | |
Operating Margin | 16.44% -33.16% | 24.60% -8.72% | 26.95% -12.23% | 30.71% -9.62% | |
Return on Assets | 8.68% -55.37% | 19.44% -20.63% | 24.49% +10.91% | 22.08% -14.25% | |
Return on Equity | 51.24% -17.05% | 61.77% +20.66% | 51.20% +26.68% | 40.41% -19.29% | |
Revenue Growth | -3.96% +6.68% | -3.72% +88.45% | -1.97% -180.71% | 2.44% -77.82% | |
Current Ratio | 0.55 +0.97% | 0.55 -18.77% | 0.67 -48.56% | 1.31 -28.32% | |
Cash Ratio | 0.11 -4.24% | 0.12 -35.80% | 0.18 -75.46% | 0.75 -44.36% | |
Debt-to-Equity Ratio | 5.65 +181.95% | 2.00 +167.41% | 0.75 +143.36% | 0.31 -1.03% | |
Debt-to-Assets Ratio | 0.59 +23.92% | 0.47 +57.84% | 0.30 +76.24% | 0.17 +0.89% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow